v3.26.1
Segment Reporting - Schedule of Consolidated Statements of Operations (Details) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
Schedule of Consolidated Statements of Operations [Line Items]        
Cost of revenues $ 235 $ 235
Gross profit 97 97
Revenues from defense business 332 332
Other Operating Segment [Member]        
Schedule of Consolidated Statements of Operations [Line Items]        
Cost of revenues 235 235
Gross profit 97 97
Revenues from defense business 332 332
Operating expenses:        
Salaries and related expenses, other than share-based compensation 429 1,932 2,202 3,909
Clinical trials 3,424 95 7,049
Stock based compensation 3,988 696 2,060 1,355
Depreciation expenses 4 292 4 528
Insurance 623 1,466
Other segment items [1] 370 1,089 883 2,348
Total Operating loss $ 5,414 $ 7,433 $ 6,710 $ 15,189
[1] Other segment items include all remaining costs necessary to operate the Company’s business, which primarily include external professional services, rent and other administrative expenses, and are presented net of grants received